Seminar from Dr. Jinjun Shi from Brigham and Women's Hospital and Harvard Medical School to highlight study of proteomic perturbations resulting from a novel approach to cancer therapy revealed using ...

Seer (SEER) will showcase new findings at the 21st Annual US Human Proteome Organization – HUPO – Conference in Philadelphia from February ...

Researchers from Bonn and Erlangen identify the protein MLC1 as a target antigen in multiple sclerosis (MS); a chronic ...

Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced the company will be ...

< Under the microscope: In the brain section of an MS patient, the neurons are shown in green and the ... University Hospital Bonn (UKB) / Research group Prof. Stefanie Kürten ...

Peptide therapy enhances targeted medicine, utilizing specific peptides for effective treatment of cancer, metabolic disorders, and neurodegenerative diseases.

This valuable study reports on the critical role of ANKRD5 (ANKEF1) in sperm motility and male fertility. However, the supporting data remain incomplete. This work will be of interest to biomedical ...

Proteomic analysis (proteomics) refers to the systematic identification and quantification of the complete complement of proteins (the proteome ... heterogeneity within human skeletal muscle ...